Cost-effectiveness analysis of implementing a secondary prevention programme in those patients who visited an emergency department for drug-related problems.
Jesús Ruiz-RamosAna Juanes-BorregoMireia Puig-CampanyMarta Blazquez-AndiónLaia López-VinardellAntonio Gilabert-PerramonJosep María Guiu-SeguraMaria Antonia Mangues-BafalluyPublished in: The International journal of pharmacy practice (2022)
Implementing a secondary prevention programme is cost-effective for patients with DRPs admitted to the emergency department. Implementation costs will be exceeded by reducing revisits to the emergency department.